Regencell Bioscience Holdings Limited
$29.09
▲
2.43%
2026-04-22 10:12:13
www.regencellbioscience.com
NCM: RGC
Explore Regencell Bioscience Holdings Limited stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$13.89 B
Current Price
$29.09
52W High / Low
$83.6 / $0.7
Stock P/E
—
Book Value
$0.01
Dividend Yield
—
ROCE
-57.45%
ROE
-54.81%
Face Value
—
EPS
$-0.01
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
10
Beta
2.25
Debt / Equity
11.2
Current Ratio
7.39
Quick Ratio
41.92
Forward P/E
—
Price / Sales
—
Enterprise Value
$14.25 B
EV / EBITDA
-3,858.53
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | BioAge Labs, Inc. | $18.8 | — | $820.58 M | — | -33.77% | -27.09% | $24 / $3.63 | $7.28 |
| 2. | Hims & Hers Health, Inc. | $28.91 | 56.32 | $6.55 B | — | 6.03% | 25.23% | $70.43 / $13.74 | $2.38 |
| 3. | Sonoma Pharmaceuticals, Inc. | $2.65 | — | $4.59 M | — | -38.66% | -81.18% | $6.92 / $2 | $1.98 |
| 4. | Zoetis Inc. | $118.25 | 19.63 | $49.71 B | 1.64% | 27.18% | 65.99% | $172.23 / $113.29 | $7.84 |
| 5. | Prestige Consumer Healthcare Inc. | $58.68 | 14.89 | $2.78 B | — | 10.6% | 10.31% | $89.37 / $51.24 | $38.66 |
| 6. | Rockwell Medical, Inc. | $0.94 | — | $37.03 M | — | -9.86% | -15.28% | $2.1 / $0.78 | $0.94 |
| 7. | Universe Pharmaceuticals INC | $3.32 | — | $1.9 M | — | -5.19% | -7.23% | $11 / $2 | $99.64 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -4.74 M | -6.27 M | -7.62 M | -1.38 M |
| Net Profit | -4.3 M | -5.87 M | -7.45 M | -1.35 M |
| EPS in Rs | -0.01 | -0.01 | -0.02 | -0 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 8.44 M | 12.62 M | 18.02 M | 0.34 M |
| Total Liabilities | 0.22 M | 0.63 M | 0.94 M | 4.34 M |
| Equity | 8.22 M | 12.03 M | 17.07 M | -4 M |
| Current Assets | 8.11 M | 11.62 M | 16.44 M | 0.07 M |
| Current Liabilities | 0.19 M | 0.61 M | 0.58 M | 4.34 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -4 M | -4.96 M | -5.27 M | -0.77 M |
| Investing CF | 5.24 M | 0.06 M | -10.78 M | 0 M |
| Financing CF | 0.1 M | 0.13 M | 22.41 M | 0.44 M |
| Free CF | -4.01 M | -4.99 M | -6.05 M | -0.77 M |
| Capex | -0.01 M | -0.03 M | -0.78 M | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 26.73% | 21.15% | -452.88% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-06-16 | 1:38 |